Rugvænget 5
Ansager 6823
Denmark
45 69 16 03 93
https://www.dancann.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo:
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Jeppe Krog Rasmussen | Founder, Member of Executive Board, Director & CEO | N/D | N/D | 1995 |
Mr. Peter Hauberg Sondergaard | Chief Financial Officer | N/D | N/D | 1972 |
Mr. Jens Markussen | Head of Production | N/D | N/D | N/D |
Mr. John Morell Frellsen | Chief Commercial Officer | N/D | N/D | N/D |
Ms. Charlotte Hagedorn Jorgensen | Head of Quality Assurance | N/D | N/D | N/D |
Dancann Pharma A/S, a biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing cannabinoid therapeutics in various disease areas. The company produces and distributes prescription and over-the-counter cannabinoid-based pharmaceuticals primarily focused on pain patients. Dancann Pharma A/S was incorporated in 2018 and is based in Ansager, Denmark.
La calificación ISS Governance QuickScore de DanCann Pharma A/S a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.